<?xml version="1.0" encoding="UTF-8"?>
<p id="par0010">Currently, there is no effective drug against COVID-19. One of the treatment alternatives used is lopinavir/ritonavir (LPV/r), which showed in vitro activity and positive clinical outcomes against coronaviruses in previous epidemics (SARS and MERS).
 <xref rid="bib0010" ref-type="bibr">
  <sup>2</sup>
 </xref> A recent study in a severe COVID-19 patient showed no clinical benefit from delayed initiation of LPV/r, so further adequately conducted studies are needed to establish the usefulness of LPV/r.
 <xref rid="bib0015" ref-type="bibr">
  <sup>3</sup>
 </xref>
</p>
